Suppr超能文献

骨质疏松症的激素预防与治疗——1990年的最新进展

Hormonal prevention and treatment of osteoporosis--state of the art 1990.

作者信息

Christiansen C

机构信息

Department of Clinical Chemistry, Glostrup Hospital, Denmark.

出版信息

J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):447-9. doi: 10.1016/0960-0760(90)90496-8.

Abstract

Osteoporosis is a growing disease, and attention should be directed to possible means of preventing and treating this disease. Osteoporosis may be caused by a number of diseases (secondary osteoporosis), but it most often occurs in otherwise healthy persons. The major risk factors are a low bone mass at skeletal maturity, and a rapid bone loss. Postmenopausal bone loss may be prevented by hormone replacement therapy. All types of oestrogens and all administration forms are effective, as long as a sufficient serum concentration is obtained. The greatest benefit of hormone replacement therapy is obtained if instituted right after the menopause, when the bone loss is most rapid. But oestrogen will also arrest the bone loss when instituted much later in life.

摘要

骨质疏松症是一种日益普遍的疾病,应关注预防和治疗该疾病的可能方法。骨质疏松症可能由多种疾病引起(继发性骨质疏松症),但最常发生在其他方面健康的人群中。主要危险因素是骨骼成熟时骨量低以及骨量快速流失。绝经后骨质流失可通过激素替代疗法预防。只要能获得足够的血清浓度,所有类型的雌激素和所有给药形式都是有效的。如果在绝经后立即开始激素替代疗法,此时骨质流失最为迅速,就能获得最大益处。但在生命后期开始使用雌激素也能阻止骨质流失。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验